Scarica l'app Stockscreener
3.98
1.14%
0.045
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché LFMD Giù?
Forum
Previsione
Frazionamento azionario
Lifemd Inc Borsa (LFMD) Ultime notizie
LifeMD (LFMD) Is Up 32.7% After Returning To Profitability And Expanding GLP‑1 Telehealth Offerings - simplywall.st
LifeMD (NASDAQ:LFMD) Upgraded to Hold at Wall Street Zen - MarketBeat
H.C. Wainwright raises LifeMD stock price target to $10 on results - Investing.com Nigeria
HC Wainwright Issues Positive Forecast for LifeMD Earnings - MarketBeat
A Look At LifeMD (LFMD) Valuation After Profitability Return And 2026 Growth Guidance - Yahoo Finance
LifeMD outlines $250M+ annualized revenue run rate target by Q4 2026 amid record GLP-1 demand and expanded partnerships - MSN
LifeMD (LFMD) Valuation Check After Earnings Beat Guidance Update And Wegovy Partnership - simplywall.st
Hims & Hers Plunges 29.4% in Three Months: How to Play the Stock? - TradingView
Freedom Capital Markets raises LifeMD stock price target on forecast boost By Investing.com - Investing.com South Africa
Freedom Capital Markets raises LifeMD stock price target on forecast boost - Investing.com
Analysts Offer Insights on Healthcare Companies: Roche Holding AG (OtherRHHVF), Centene (CNC) and LifeMD (LFMD) - The Globe and Mail
LifeMD: Wegovy Pill, Net Cash, And Low Multiple Sets Up Longs For Possible Alpha - Seeking Alpha
LifeMD, Inc. 2025 Annual Report: Virtual Healthcare, Telehealth Growth, and Integrated Pharmacy Platform 101 - Minichart
HC Wainwright Increases LifeMD (NASDAQ:LFMD) Price Target to $10.00 - MarketBeat
LifeMD (LFMD): HC Wainwright Raises Price Target While Maintaini - GuruFocus
LifeMD (LFMD) Trailing Losses Narrow To US$14.6m Challenging Bearish Profitability Narratives - Sahm
Cantor Fitzgerald Maintains Overweight on LifeMD, Inc. (LFMD) March 2026 - Meyka
LifeMD 10-K: Telehealth revenue $194.1M, Net income $15.62M - TradingView
LifeMD Issues 2026 Outlook Amid Strong 2025 Growth - The Globe and Mail
LifeMD (NASDAQ: LFMD) grows 2025 telehealth revenue 25% as losses narrow - Stock Titan
LifeMD (LFMD) Soars After Strong Q4 Results and Positive Outlook - GuruFocus
Cantor Fitzgerald reiterates Overweight on LifeMD stock, $15 target By Investing.com - Investing.com Australia
LifeMD soars as Cantor Fitzgerald reportedly reiterates Overweight rating following solid Q4 print - Seeking Alpha
Cantor Fitzgerald reiterates Overweight on LifeMD stock, $15 target - Investing.com
BTIG Research Reiterates Buy Rating for LifeMD (NASDAQ:LFMD) - MarketBeat
LifeMD (LFMD) Receives Analyst Rating Reiteration from BTIG | LF - GuruFocus
LifeMD options imply 10.9% move in share price post-earnings - TipRanks
LifeMD rises on Q4 2025 beats, 2026 revenue guidance midpoint above consensus - MSN
LifeMD Inc (LFMD) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
LifeMD Q4 2025 Earnings Call Transcript - MarketBeat
LifeMD Inc (LFMD) Q4 2025 Earnings Call Highlights: Strong Reven - GuruFocus
LifeMD Inc reports results for the quarter ended December 31Earnings Summary - TradingView
LifeMD (LFMD) Reports Strong Growth and Strategic Partnerships - GuruFocus
LifeMD, Inc. (LFMD) Reports Q4 Loss, Tops Revenue Estimates - Bitget
LifeMD Q4 Earnings Call Highlights - MarketBeat
LifeMD (LFMD) Shares Surge After Beating Q4 2025 Expectations - GuruFocus
LifeMD earnings beat by $0.03, revenue fell short of estimates - Investing.com Canada
LifeMD: Q4 Earnings Insights - Benzinga
LifeMD reports Q4 EPS 41c, consensus 3c - TipRanks
LifeMD (LFMD) Reports Strong Q4 Revenue and Expanding Telehealth Subscriber Base - GuruFocus
LifeMD (LFMD) Projects Q1 EBITDA Loss, Anticipates Rebound in Q2 - GuruFocus
LifeMD (LFMD) Projects Strong Financial Growth for 2026 - GuruFocus
LifeMD surges 11.5% on Q4 earnings beat, FY guidance - Investing.com South Africa
LifeMD (NASDAQ:LFMD) Releases Quarterly Earnings Results, Beats Expectations By $0.42 EPS - MarketBeat
LIFEMD ($LFMD) Releases Q4 2025 Earnings, Stock Rises - Quiver Quantitative
LifeMD 2025 revenue jumps 25% to $194M, guides 2026 - National Today
[8-K] LifeMD, Inc. Reports Material Event | LFMD SEC FilingForm 8-K - Stock Titan
LifeMD Q4 revenue rises but misses estimates - TradingView
LifeMD Reports Fourth Quarter and Full Year 2025 Results - marketscreener.com
LifeMD, Inc. Provides Earnings Guidance for the First Quarter and Full Year 2026 - marketscreener.com
BREAKING: LFMD Reports Q4 Earnings - AlphaStreet
LifeMD (LFMD) Earnings Date and Reports 2026 - MarketBeat
LifeMD’s GLP-1 Growth Looks Real, But The Stock’s Still Cheap - Finimize
LifeMD Inc expected to post a loss of 3 cents a shareEarnings Preview - TradingView
0.79%
1.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):